Grimes & Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.15M | Sell |
|
|||||
2025
Q1 | $8.12M | Buy |
|
|||||
2024
Q4 | $3.92M | Sell |
|
|||||
2024
Q3 | $9.2M | Sell |
|
|||||
2024
Q2 | $11.1M | Buy |
|
|||||
2024
Q1 | $10.1M | Buy |
|
|||||
2023
Q4 | $11.7M | Buy |
|
|||||
2023
Q3 | $11.5M | Buy |
|
|||||
2023
Q2 | $12.6M | Sell |
|
|||||
2023
Q1 | $12.4M | Sell |
|
|||||
2022
Q4 | $12.7M | Sell |
|
|||||
2022
Q3 | $12.5M | Buy |
|
|||||
2022
Q2 | $9.41M | Buy |
|
|||||
2022
Q1 | $9.52M | Buy |
|
|||||
2021
Q4 | $9.96M | Sell |
|
|||||
2021
Q3 | $11.8M | Sell |
|
|||||
2021
Q2 | $14.5M | Sell |
|
|||||
2021
Q1 | $11.8M | Buy |
|
|||||
2020
Q4 | $9.48M | Buy |
|
|||||
2020
Q3 | $10.1M | Buy |
|
|||||
2020
Q2 | $8.61M | Sell |
|
|||||
2020
Q1 | $10.2M | Sell |
|
|||||
2019
Q4 | $9.71M | Sell |
|
|||||
2019
Q3 | $8.84M | Buy |
|
|||||
2019
Q2 | $412K | Sell |
|
|||||
2019
Q1 | $653K | Buy |
|
|||||
2018
Q4 | $530K | Sell |
|
|||||
2018
Q3 | $725K | Buy |
|
|||||
2018
Q2 | $569K | Buy |
|
|||||
2018
Q1 | $364K | Sell |
|
|||||
2017
Q4 | $435K | Hold |
|
|||||
2017
Q3 | $427K | Hold |
|
|||||
2017
Q2 | $370K | Hold |
|
|||||
2017
Q1 | $373K | Hold |
|
|||||
2016
Q4 | $387K | Hold |
|
|||||
2016
Q3 | $427K | Sell |
|
|||||
2016
Q2 | $383K | Hold |
|
|||||
2016
Q1 | $413K | Buy |
|
|||||
2015
Q4 | $443K | Sell |
|
|||||
2015
Q3 | $433K | Sell |
|
|||||
2015
Q2 | $680K | Buy |
|
|||||
2015
Q1 | $652K | Buy |
|
|||||
2014
Q4 | $522K | Sell |
|
|||||
2014
Q3 | $522K | Buy |
|
|||||
2014
Q2 | $481K | Buy |
|
|||||
2014
Q1 | $360K | Buy |
|
|||||
2013
Q4 | $269K | Hold |
|
|||||
2013
Q3 | $232K | Buy |
|